China Molecular Diagnostics Market, Volume, by Application [Oncology Testing (Breast Cancer, Colorectal Cancer, Prostate Cancer), Infectious Disease Testing (Virology, HPV), and Genetic Disease Testing (Blood Screening, HLA)]

Publisher Name :
Date: 17-Aug-2018
No. of pages: 100
Inquire Before Buying

China Molecular Diagnostics Market is projected to reach US$ 1.8 Billion by the end of year 2024. Molecular diagnostics is a technique which is used for the molecular biological detection of any change in the structure or expression of patient’s genetic material. Molecular diagnostics plays an essential role in the detection and identification of various diseases and has gained more public & healthcare specialist attention than ever before. Today, Molecular diagnostics is changing the face of clinical laboratories by offering easy to use automated molecular systems that provide rapid results with less hands-on time.

China Molecular Diagnostics Market is growing rapidly due to the rising incidence of cancer and infectious diseases in the region. In addition; growing wealthy middle class population, who now are willing to pay more in availing better healthcare facilities and aging population who are more vulnerable to communicable diseases and the development in Chinese healthcare infrastructure are some other factors which are expected to drive China Molecular Diagnostics Market to a new record in the forthcoming years.

The report titled “China Molecular Diagnostics Market, Volume, by Application [Oncology Testing (Breast Cancer, Colorectal Cancer, Prostate Cancer), Infectious Disease Testing (Virology, HPV), and Genetic Disease Testing (Blood Screening, HLA)]” provides a complete analysis of China Molecular Diagnostics Market.

By Application – Oncology and Infectious Disease Driving the China Molecular Diagnostics Market

The report studies the market and volume of the following Molecular Diagnostics segments: Oncology Testing (Breast Cancer, Colorectal Cancer, Prostate Cancer), Infectious Disease Testing (Virology, HPV) and Genetic Disease Testing (Blood Screening, HLA). Due to the rising cancer cases and infectious diseases in the China, it is believed that Oncology testing and Infectious disease testing leads the China Molecular Diagnostics Market in terms of both market & volume.

The report China Molecular Diagnostics Market has been studied from 7 viewpoints:


  • Market & Forecast

  • Volume & Forecast

  • Segments – Market Share & Forecast

  • Segments – Volume Share & Forecast

  • Profiles of Private Clinical Labs and Diagnostic Services

  • Growth Drivers for China Molecular Diagnostics

  • Challenges for China Molecular Diagnostics


This market research report provides a complete analysis of the China Molecular Diagnostics Market, Volume, Growth Drivers, Challenges, and their projections for the upcoming years.

Segment Covered in this report are as follows:

Oncology Testing Market and Volume


  • Breast Cancer

  • Colorectal Cancer

  • Prostate Cancer


Infectious Disease Testing Market and Volume


  • Virology

  • HPV


Genetic Testing Market and Volume


  • Blood Screening

  • HLA


Profiles of Private Clinical Labs and Diagnostic Services Companies in China


  • Zhejiang Di’an Diagnostics Technology Co., Ltd

  • ADICON Clinical Laboratories

  • Guangzhou Kingmed Diagnostics Center Co. Ltd.

  • Kindstar Global (Privately held)

  • BGI-Shenzhen (Privately held)

  • OriGene Technologies (Privately held)

China Molecular Diagnostics Market, Volume, by Application [Oncology Testing (Breast Cancer, Colorectal Cancer, Prostate Cancer), Infectious Disease Testing (Virology, HPV), and Genetic Disease Testing (Blood Screening, HLA)]

Table of Contents

1. Executive Summary

2. China Molecular Diagnostic Market & Test Volume
2.1 China Molecular Diagnostic Market
2.2 China Molecular Diagnostic Test Volume

3. Market Share – China Molecular Diagnostic Volume Share Analysis
3.1 Segments
3.2 Disease
3.3 Oncology Test
3.4 Genetic Test
3.5 Infectious Disease Test

4. Volume Share – China Molecular Diagnostics
4.1 Segments
4.2 Disease
4.3 Oncology Test
4.4 Infectious Disease Test
4.5 Genetic Test

5. Disease – China Molecular Diagnostic Test Volume
5.1 Oncology Test Volume
5.1.1 Breast Cancer Test Volume
5.1.2 Colorectal Cancer Test Volume
5.1.3 Prostate Cancer Test Volume
5.2 Infectious Disease Test Volume
5.2.1 Virology Test Volume
5.2.2 HPV Test Volume
5.3 Genetic Test Volume
5.3.1 Blood Screening Test Volume
5.3.2 HLA Test Volume

6. Disease – China Molecular Diagnostic Market
6.1 Oncology Testing Market
6.1.1 Breast Cancer Testing Market
6.1.2 Colorectal Cancer Testing Market
6.1.3 Prostate Cancer Testing Market
6.2 Infectious Disease Testing Market
6.2.1 Virology Testing Market
6.2.2 HPV Testing Market
6.3 Genetic Testing Market
6.3.1 Blood Screening Market
6.3.2 HLA Testing Market

7. China Healthcare Insurance Schemes
7.1 China Healthcare Insurance Schemes

7.1.1 New Rural Cooperative Medical Scheme (NRCMS)
7.1.2 Urban Employed Basic Medical Insurance (UEBMI)
7.1.3 Urban Resident Basic Medical Insurance (URBMI)
7.1.4 Private Health Insurance

8. Growth Drivers
8.1 Increasing Demand from Middle Class for High Quality Healthcare Products
8.2 Rising Incidences of Lifestyle Diseases in China
8.3 Rapid Development in the Diagnosis of Infectious Diseases in China
8.4 Growth in Private Hospitals & Independent Diagnostic Centers
8.4.1 Increasing the Number of Hospital Beds across all Medical Institutions

9. Challenges
9.1 Lack of Government Support, Public Awareness for Molecular Diagnostics test
9.2 Shortage of Skilled Technicians in China
9.3 Reimbursement Rates varies from Province to Province in China
9.3.1 Chinese Government Regulating Laboratory Testing in China

10. Profiles of Private Clinical Labs and Diagnostic Services Companies
10.1 Zhejiang Di’an Diagnostics Technology Co., Ltd.
10.1.1 Company Overview
10.1.2 Products and Services Offered by Di’an
10.2 ADICON Clinical Laboratories (Privately held)
10.2.1 Company Overview
10.2.2 Products and Services Offered by ADICON
10.3 Guangzhou Kingmed Diagnostics Center Co. Ltd.
10.3.1 Company Overview
10.3.2 Products and Services Offered by Kingmed
10.4 Kindstar Global (Privately held)
10.4.1 Company Overview
10.4.2 Products and Services Offered by Kindstar
10.5 BGI–Shenzhen
10.5.1 Company Overview
10.5.2 BGI’s Innovative Approach
10.6 OriGene Technologies
10.6.1 Company Overview
10.6.2 Products and Services Offered by OriGene

List of Tables:

Table 3–1: China – Molecular Diagnostic Application Market Share (Percent), 2011 – 2017
Table 3–2: China – Forecast for Molecular Diagnostic Application Market Share (Percent), 2018 – 2024
Table 3–3: China – Molecular Genetic Test Market Share (Percent), 2011 – 2017
Table 3–4: China – Forecast for Molecular Genetic Test Market Share (Percent), 2018 – 2024
Table 3–5: China – Molecular Infectious Disease Test Market Share (Percent), 2011 – 2017
Table 3–6: China – Forecast for Molecular Infectious Disease Test Market Share (Percent), 2018 – 2024
Table 4–1: China – Molecular Diagnostic Test Volume Application Share (Percent), 2011 – 2017
Table 4–2: China – Forecast for Molecular Diagnostic Test Volume Application Share (Percent), 2018 – 2024
Table 4–3: China – Molecular Infectious Disease Test Volume Share (Percent), 2011 – 2017
Table 4–4: China – Forecast for Molecular Infectious Disease Test Volume Share (Percent), 2018 – 2024
Table 4–5: China – Molecular Genetic Test Volume Share (Percent), 2011 – 2017
Table 4–6: China – Forecast for Molecular Genetic Test Volume Share (Percent), 2018 – 2024
Table 8–1: China – Major Diagnostic Reagent R&D and Manufacturing Companies in Infectious Diseases, 2010
Table 8‑2: Number of hospital beds for every 1,000 people

List of Figures:

Figure 2–1: China – Molecular Diagnostic Market (Billion US$), 2011 – 2017
Figure 2–2: China – Forecast for Molecular Diagnostic Market (Billion US$), 2018 – 2024
Figure 2–3: China – Molecular Diagnostic Test Volume (Million), 2011 – 2017
Figure 2–4: China – Forecast for Molecular Diagnostic Test Volume (Million), 2018 – 2024
Figure 3–1: China – Molecular Diagnostic Market Share (Percent), 2011 – 2017
Figure 3–2: China – Forecast for Molecular Diagnostic Market Share (Percent), 2018 – 2024
Figure 3–3: China – Molecular Oncology Test Market Share (Percent), 2011 – 2017
Figure 3–4: China – Forecast for Molecular Oncology Test Market Share (Percent), 2018 – 2024
Figure 4–1: China – Molecular Diagnostic Test Volume Share (Percent), 2011 – 2017
Figure 4–2: China – Forecast for Molecular Diagnostic Test Volume Share (Percent), 2018 – 2024
Figure 4–3: China – Molecular Oncology Test Volume Share (Percent), 2011 – 2017
Figure 4–4: China – Forecast for Molecular Oncology Test Volume Share (Percent), 2018 – 2024
Figure 5–1: Rural China – Cancer Screening Sites by Cancer Type (Number), 2013
Figure 5–2: China – Oncology Test Volume (Million), 2011 – 2017
Figure 5–3: China – Forecast for Oncology Test Volume (Million), 2018 – 2024
Figure 5–4: China –Breast Cancer Molecular Test Volume (Million), 2011 – 2017
Figure 5–5: China – Forecast for Breast Cancer Molecular Test Volume (Million), 2018 – 2024
Figure 5–6: China – Colorectal Cancer Test Volume (Million), 2011 – 2017
Figure 5–7: China – Forecast for Colorectal Cancer Test Volume (Million), 2018 – 2024
Figure 5–8: China –Prostate Cancer Test Volume (Million), 2011 – 2017
Figure 5–9: China – Forecast for Prostate Cancer Test Volume (Million), 2018 – 2024
Figure 5–10: China – Infectious Disease Test Volume (Million), 2011 – 2017
Figure 5–11: China – Forecast for Infectious Disease Test Volume (Million), 2018 – 2024
Figure 5–12: China –Virology Test Volume (Million), 2011 – 2017
Figure 5–13: China – Forecast for Virology Test Volume (Million), 2018 – 2024
Figure 5–14: China –HPV Test Volume (Thousand), 2011 – 2017
Figure 5–15: China – Forecast for HPV Test Volume (Thousand), 2018 – 2024
Figure 5–16: China –Genetic Test Volume (Million), 2011 – 2017
Figure 5–17: China – Forecast for Genetic Test Volume (Million), 2018 – 2024
Figure 5–18: China –Blood Screening Test Volume (Million), 2011 – 2017
Figure 5–19: China – Forecast for Blood Screening Test Volume (Million), 2018 – 2024
Figure 5–20: China – HLA Test Volume (Thousand), 2011 – 2017
Figure 5–21: China – Forecast for HLA Test Volume (Thousand), 2018 – 2024
Figure 6–1: China –Oncology Testing Market (Million US$), 2011 – 2017
Figure 6–2: China – Forecast for Oncology Testing Market (Million US$), 2018 – 2024
Figure 6–3: China –Breast Cancer Testing Market (Million US$), 2011 – 2017
Figure 6–4: China – Forecast for Breast Cancer Testing Market (Million US$), 2018 – 2024
Figure 6–5: China –Colorectal Cancer Testing Market (Million US$), 2011 – 2017
Figure 6–6: China – Forecast for Colorectal Cancer Testing Market (Million US$), 2018 – 2024
Figure 6–7: China –Prostate Cancer Testing Market (Million US$), 2011 – 2017
Figure 6–8: China – Forecast for Prostate Cancer Testing Market (Million US$), 2018 – 2024
Figure 6–9: China –Infectious Disease Testing Market (Million US$), 2011 – 2017
Figure 6–10: China – Forecast for Infectious Disease Testing Market (Million US$), 2018 – 2024
Figure 6–11: China –Virology Testing Market (Million US$), 2011 – 2017
Figure 6–12: China – Forecast for Virology Testing Market (Million US$), 2018 – 2024
Figure 6–13: China –HPV Testing Market (Million US$), 2011 – 2017
Figure 6–14: China – Forecast for HPV Testing Market (Million US$), 2018 – 2024
Figure 6–15: China –Genetic Testing Market (Million US$), 2011 – 2017
Figure 6–16: China – Forecast for Genetic Testing Market (Million US$), 2018 – 2024
Figure 6–17: China –Blood Screening Market (Million US$), 2011 – 2017
Figure 6–18: China – Forecast for Blood Screening Market (Million US$), 2018 – 2024
Figure 6–19: China – HLA Testing Market (Thousand US$), 2011 – 2017
Figure 6–20: China – Forecast for HLA Testing Market (Thousand US$), 2018 – 2024
Figure 8–1: China – Healthcare Spending (Billion US$), 2011 & 2020
Figure 10–1: Kindstar – Collaboration with Hospitals in China (Number), 2006 – 2012

  • Molecular Diagnostics Collaboration and Licensing Deals 2016-2023
    Published: 01-Nov-2023        Price: US 3995 Onwards        Pages: 400
    Molecular Diagnostics Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the molecular diagnostics deals entered into by the worlds leading biopharma companies. Fully revised and updated, the report provides details of molecular diagnostics deals from 2016 to 2023. The report provides a detailed understanding and analysis of how and why companies enter molecular diagnostics deals. These deals tend to be multicomponent, s......
  • Global Molecular Diagnostic Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 31-Oct-2023        Price: US 3380 Onwards        Pages: 120
    Market Overview of Global Molecular Diagnostic market: According to our latest research, the global Molecular Diagnostic market looks promising in the next 5 years. As of 2022, the global Molecular Diagnostic market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Molecular D......
  • Global Core Clinical Molecular Diagnostics Market (2023 Edition): Analysis By Technology (ISH, PCR, Sequencing, Others), By Application (Infectious Disease and Blood Screening, Genetic Testing, Cancer Screening, Others), By Region, By Country: Market Insights and Forecast (2019-2029)
    Published: 01-Oct-2023        Price: US 2450 Onwards        Pages: 220
    Executive Summary Azoth Analytics has released a research report titled "Global Core Clinical Molecular Diagnostics Market (2023 Edition)" which provides a complete analysis of the Global Core Clinical Molecular Diagnostics industry in terms of market segmentation By Technology (In situ hybridization, Polymerase Chain Reaction, Sequencing, Others) and By Application (Infectious Disease and Blood Screening, Genetic Testing, Cancer Screening, Other Applications) for the historical p......
  • Global Molecular Diagnostics Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Sep-2023        Price: US 3380 Onwards        Pages: 112
    Market Overview of Global Molecular Diagnostics market: According to our latest research, the global Molecular Diagnostics market looks promising in the next 5 years. As of 2022, the global Molecular Diagnostics market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Molecular diagnosis refers to applying molecular biology methods to detect changes in the structure or expression level of genet......
  • Global Molecular Diagnostics in Infectious Disease Testing Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 31-Aug-2023        Price: US 3380 Onwards        Pages: 101
    Market Overview of Global Molecular Diagnostics in Infectious Disease Testing market: According to our latest research, the global Molecular Diagnostics in Infectious Disease Testing market looks promising in the next 5 years. As of 2022, the global Molecular Diagnostics in Infectious Disease Testing market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time spa......
  • Global Molecular Diagnostics Market Insights, Forecast to 2029
    Published: 14-Aug-2023        Price: US 4900 Onwards        Pages: 114
    Molecular diagnostics market employs a range of systems, including real-time PCR systems, liquid handling systems, and DNA extraction systems, among others. Real-time PCR systems are commonly known as quantitative PCR systems. These systems monitor the amplification of the targeted DNA molecule during the exponential phase. The commonly used detection methods in these systems include fluorescent dyes and sequence specific DNA probes. Market Analysis and Insights: Global Molecular Diagnost......
  • Global Molecular Diagnostics Market 2023
    Published: 13-Aug-2023        Price: US 2450 Onwards        Pages: 89
    Description According to the latest data, the market size of the global satellite imaging for agriculture sector is expected to rise by USD 234.5 million with a CAGR of 6.26% by the end of 2029. The implementation of satellite imaging in agriculture involves utilizing satellites to capture high-resolution images of agricultural land. These images offer valuable data and insights that can be leveraged to improve agricultural systems and enhance farming practices. One of the key......
  • Global Molecular Diagnostics in Infectious Disease Testing Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 22-Jun-2023        Price: US 3260 Onwards        Pages: 129
    The Molecular Diagnostics in Infectious Disease Testing market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Molecular Diagnostics in Infectious Disease Testing industry, and breaks down according to the type, application, and consumption area of Molecular Diagnostics in Infectious Disease Testing. The report also introduces pla......
  • Point of Care Molecular Diagnostics Market by Product (Assays, Kits, Instruments, Software), Application (Respiratory Diseases, HAIs, Cancer, STDs, Hepatitis), Technology (RT-PCR, INAAT), End User (Clinics, Hospitals, ICUs) & Region - Global Forecast to 2028
    Published: 14-Jun-2023        Price: US 4950 Onwards        Pages: 212
    “Increasing prevalence of infectious diseases and cancer and the rising funding for R&D are driving the overall growth of the point-of-care molecular diagnostics market” The global point-of-care molecular diagnostics market size is projected to reach USD 3.4 billion by 2028 from USD 2.0 billion in 2023, at a CAGR of 10.6% during the forecast period. Market growth is driven by factors such as the increasing prevalence of infectious dise......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs